BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1754701)

  • 1. [Assessment of costs of health insurance, substitution therapy in chronic renal insufficiency].
    Chanut C; Barnouin F; Benech JM; Bouvier P; Briat C; Hecht M; Pollini J; Soutif C; Toselli A
    Rev Epidemiol Sante Publique; 1991; 39(4):353-64. PubMed ID: 1754701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analysis of alternative treatments in end-stage renal disease.
    Karlberg I
    Transplant Proc; 1992 Feb; 24(1):335. PubMed ID: 1539301
    [No Abstract]   [Full Text] [Related]  

  • 4. The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.
    Rodríguez-Carmona A; Perez Fontán M; Bouza P; García Falcón T; Valdés F
    Adv Perit Dial; 1996; 12():93-6. PubMed ID: 8865880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost of dialysis in France].
    Benain JP; Faller B; Briat C; Jacquelinet C; Brami M; Aoustin M; Dubois JP; Rieu P; Behaghel C; Duru G
    Nephrol Ther; 2007 Jun; 3(3):96-106. PubMed ID: 17540311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Self dialysis: a new method of treatment for end-stage renal disease].
    Fournier G; Gaillard JL; Matha N; Man NK
    Nephrologie; 1984; 5(3):115-8. PubMed ID: 6493429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The costs of dialysis treatments for patients with end-stage renal disease in France.
    Jacobs C
    Nephrol Dial Transplant; 1997; 12 Suppl 1():29-32. PubMed ID: 9075226
    [No Abstract]   [Full Text] [Related]  

  • 9. A cost effectiveness analysis of the treatment of end stage renal failure.
    Croxson BE; Ashton T
    N Z Med J; 1990 Apr; 103(888):171-4. PubMed ID: 2109846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of hemodialysis in Iran.
    Arefzadeh A; Lessanpezeshki M; Seifi S
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):307-11. PubMed ID: 19237828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Costs of chronic dialysis in a public hospital: myths and realities].
    Lamas J; Alonso M; Saavedra J; García-Trío G; Rionda M; Ameijeiras M
    Nefrologia; 2001; 21(3):283-94. PubMed ID: 11471309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost of dialysis in France].
    Zambrowski JJ
    Nephrol Ther; 2016 Apr; 12 Suppl 1():S95-7. PubMed ID: 26972098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare's ESRD Program, Part 1: Dialysis.
    Long HW
    Physician Exec; 1989; 15(2):24-6. PubMed ID: 10313034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The costs of dialysis in Canada.
    Prichard SS
    Nephrol Dial Transplant; 1997; 12 Suppl 1():22-4. PubMed ID: 9075224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of an ambulatory program devoted to chronic renal insufficiency on the reduction of mobidity and hospitalization among patients at the beginning of dialysis treatment].
    Malberti F; Ravani P
    G Ital Nefrol; 2003; 20(2):127-32. PubMed ID: 12746797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dialysis versus renal transplantation; a comparative study on medical cost and quality of life in patients with chronic renal failure].
    Tajima A; Ueda D; Hirai M; Morinaga S; Sudoko H; Yamaguchi Y; Mitsuhashi T; Nakano M; Kanbayashi T; Ushiyama T
    Hinyokika Kiyo; 1987 Oct; 33(10):1536-41. PubMed ID: 3128069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy.
    Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF
    Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sociological diagnosis in the selection of rehabilitation methods for the uremic patient].
    Urdaneta Carruyo ER; Otañez Pineda E; Gordillo-Paniagua G
    Bol Med Hosp Infant Mex; 1981; 38(5):777-86. PubMed ID: 7034743
    [No Abstract]   [Full Text] [Related]  

  • 20. Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil.
    Sesso R; da Silva CB; Kowalski SC; Manfredi SR; Canziani ME; Draibe SA; Elgazzar HA; Ferraz MB
    Int J Technol Assess Health Care; 2007; 23(1):126-30. PubMed ID: 17234026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.